MYNZ Stock Analysis: Buy, Sell, or Hold?
MYNZ - Mainz Biomed N.V. Ordinary Shares
$0.84
0.02 (2.07%)
â˛
5d:
-7.24%
30d:
-2.44%
90d:
-21.84%
WAIT
LOW Confidence
Analysis Updated: Mar 11, 2026 12:00 AM ET
Earnings: Apr 07, 2026
0d
Get Alerted When MYNZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MYNZ is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MYNZ is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MYNZ is currently trading at $0.84, which is considered fair based on recent price action.
Technical Outlook: Technically, MYNZ is in a strong downtrend. Immediate support is located at $0.59, while resistance sits at $0.94.
Market Sentiment: MYNZ scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+1558.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYNZ is in a strong downtrend. Immediate support is located at $0.59, while resistance sits at $0.94.
Market Sentiment: MYNZ scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+1558.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 1558.6% below Wall St target ($14.00)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.94
Current Trend
Strong Downtrend
Technical data as of
Mar 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.63
Wall Street Target
$14.00
(+1558.6%)
Revenue Growth (YoY)
-44.9%
Share & Embed Analysis
Last updated: August 20, 2026 7:52 AM ET
Data refreshes hourly during market hours. Next update: 8:52 AM
Data refreshes hourly during market hours. Next update: 8:52 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYNZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 37 SELL |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 33 SELL |
